TRIF is a critical survival factor in viral cardiomyopathy

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 2561-2570

  Riad, Alexander ^a   Westermann, Dirk ^b   Zietsch, Christin ^b   Savvatis, Konstantinos ^b   Becher, Peter M ^b   Bereswill, Stefan ^b   Heimesaat, Markus M ^b   Lettau, Olga ^b   Lassner, Dirk ^b   Dörner, Andrea ^b   Poller, Wolfgang ^b   Busch, Matthias ^a   Felix, Stephan B ^a   Schultheiss, Heinz P ^b   Tschöpe, Carsten ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; DISEASE SEVERITY; HEART FAILURE; HEART MUSCLE CELL; HEART PROTECTION; MALE; MORTALITY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL; VIRUS MYOCARDITIS; WILD TYPE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HEART FAILURE; HELA CELLS; HUMANS; INTERFERON-BETA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDITIS; SEROTYPING; VENTRICULAR DYSFUNCTION, LEFT; VIRUS REPLICATION;

EID: 79951841874     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002029     Document Type: Article

References (45)

1. Woodruff, J. F. 1980. Viral myocarditis: a review. Am. J. Pathol. 101: 425-484.
2. Rosamond, W., K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 2008. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-e146.
3. Liu, P., K. Aitken, Y. Y. Kong, M. A. Opavsky, T. Martino, F. Dawood, W. H. Wen, I. Kozieradzki, K. Bachmaier, D. Straus, et al. 2000. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nat. Med. 6: 429-434.
4. Calabrese, F., E. Rigo, O. Milanesi, G. M. Boffa, A. Angelini, M. Valente, and G. Thiene. 2002. Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn. Mol. Pathol. 11: 212-221.
5. Leonard, E. G. 2004. Viral myocarditis. Pediatr. Infect. Dis. J. 23: 665-666.
6. Tschöpe, C., C. T. Bock, M. Kasner, M. Noutsias, D. Westermann, P. L. Schwimmbeck, M. Pauschinger, W. C. Poller, U. Kühl, R. Kandolf, and H. P. Schultheiss. 2005. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111: 879-886.
7. Fuse, K., G. Chan, Y. Liu, P. Gudgeon, M. Husain, M. Chen, W. C. Yeh, S. Akira, and P. P. Liu. 2005. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 112: 2276-2285.
8. Deonarain, R., D. Cerullo, K. Fuse, P. P. Liu, and E. N. Fish. 2004. Protective role for interferon-b in coxsackievirus B3 infection. Circulation 110: 3540-3543.
9. O'Neill, L. A. 2008. When signaling pathways collide: positive and negative regulation of Toll-like receptor signal transduction. Immunity 29: 12-20. (Pubitemid 351952460)
10. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364.
11. Riad, A., T. Walther, J. Yang, C. Altmann, F. Escher, D. Westermann, F. Spillmann, H. P. Schultheiss, and C. Tschöpe. 2008. The cardiovascular influence of interleukin-1β on the expression of bradykinin B1 and B2 receptors. Int. Immunopharmacol. 8: 222-230.
12. Fairweather, D., S. Yusung, S. Frisancho, M. Barrett, S. Gatewood, R. Steele, and N. R. Rose. 2003. IL-12 receptor β1 and Toll-like receptor 4 increase IL-1band IL-18-associated myocarditis and coxsackievirus replication. J. Immunol. 170: 4731-4737.
13. Fairweather, D., S. Frisancho-Kiss, and N. R. Rose. 2005. Viruses as adjuvants for autoimmunity: evidence from coxsackievirus-induced myocarditis. Rev. Med. Virol. 15: 17-27.
14. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301: 640-643. (Pubitemid 36927946)
15. Heymans, S., E. Hirsch, S. D. Anker, P. Aukrust, J. L. Balligand, J. W. Cohen-Tervaert, H. Drexler, G. Filippatos, S. B. Felix, L. Gullestad, et al. 2009. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 11: 119-129.
16. Pankuweit, S., I. Portig, and B. Maisch. 2002. Pathophysiology of cardiac inflammation: molecular mechanisms. Herz 27: 669-676. (Pubitemid 35415252)
17. Riad, A., S. Bien, M. Gratz, F. Escher, D. Westermann, M. M. Heimesaat, S. Bereswill, T. Krieg, S. B. Felix, H. P. Schultheiss, et al. 2008. Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice. Eur. J. Heart Fail. 10: 233-243.
18. Riad, A., S. Jäger, M. Sobirey, F. Escher, A. Yaulema-Riss, D. Westermann, A. Karatas, M. M. Heimesaat, S. Bereswill, D. Dragun, et al. 2008. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J. Immunol. 180: 6954-6961.
19. Krupinski, J., M. M. Turu, J. Martinez-Gonzalez, A. Carvajal, J. O. Juan-Babot, E. Iborra, M. Slevin, F. Rubio, and L. Badimon. 2006. Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke 37: 1200-1204. (Pubitemid 43731862)
20. Abruzzo, L. V., K. Y. Lee, A. Fuller, A. Silverman, M. J. Keating, L. J. Medeiros, and K. R. Coombes. 2005. Validation of oligonucleotide microarray data using microfluidic low-density arrays: a new statistical method to normalize real-time RT-PCR data. Biotechniques 38: 785-792.
21. Claudio, E., S. U. Sønder, S. Saret, G. Carvalho, T. R. Ramalingam, T. A. Wynn, A. Chariot, A. Garcia-Perganeda, A. Leonardi, A. Paun, et al. 2009. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J. Immunol. 182: 1617-1630.
22. Fletcher, J. M., M. A. Jordan, S. L. Snelgrove, R. M. Slattery, F. D. Dufour, K. Kyparissoudis, G. S. Besra, D. I. Godfrey, and A. G. Baxter. 2008. Congenic analysis of the NKT cell control gene Nkt2 implicates the peroxisomal protein Pxmp4. J. Immunol. 181: 3400-3412.
23. Westermann, D., J. Mersmann, A. Melchior, T. Freudenberger, C. Petrik, L. Schaefer, R. Lüllmann-Rauch, O. Lettau, C. Jacoby, J. Schrader, et al. 2008. Biglycan is required for adaptive remodeling after myocardial infarction. Circulation 117: 1269-1276. (Pubitemid 351365659)
24. Westermann, D., S. Rutschow, S. Jäger, A. Linderer, S. Anker, A. Riad, T. Unger, H. P. Schultheiss, M. Pauschinger, and C. Tschöpe. 2007. Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism. Diabetes 56: 641-646. (Pubitemid 46348458)
25. Dörner, A., H. P. Grunert, V. Lindig, K. Chandrasekharan, H. Fechner, K. U. Knowlton, A. Isik, M. Pauschinger, H. Zeichhardt, and H. P. Schultheiss. 2006. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury. J. Mol. Med. 84: 842-851.
26. Suckau, L., H. Fechner, E. Chemaly, S. Krohn, L. Hadri, J. Kockskämper, D. Westermann, E. Bisping, H. Ly, X. Wang, et al. 2009. Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation 119: 1241-1252.
27. Kawai, C. 1999. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 99: 1091-1100. (Pubitemid 29104501)
28. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
29. Oshiumi, H., M. Matsumoto, K. Funami, T. Akazawa, and T. Seya. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-b induction. Nat. Immunol. 4: 161-167.
30. Blyszczuk, P., G. Kania, T. Dieterle, R. R. Marty, A. Valaperti, C. Berthonneche, T. Pedrazzini, C. T. Berger, S. Dirnhofer, C. M. Matter, et al. 2009. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ. Res. 105: 912-920.
31. Triantafilou, K., G. Orthopoulos, E. Vakakis, M. A. Ahmed, D. T. Golenbock, P. M. Lepper, and M. Triantafilou. 2005. Human cardiac inflammatory responses triggered by coxsackie B viruses are mainly Toll-like receptor (TLR) 8-ependent. Cell. Microbiol. 7: 1117-1126.
32. Smiley, S. T., J. A. King, and W. W. Hancock. 2001. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167: 2887-2894.
33. Timmers, L., J. P. Sluijter, J. K. van Keulen, I. E. Hoefer, M. G. Nederhoff, M. J. Goumans, P. A. Doevendans, C. J. van Echteld, J. A. Joles, P. H. Quax, et al. 2008. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ. Res. 102: 257-264.
34. Nozaki, N., T. Shishido, Y. Takeishi, and I. Kubota. 2004. Modulation of doxorubicin-induced cardiac dysfunction in Toll-like receptor-2-knockout mice. Circulation 110: 2869-2874. (Pubitemid 39473611)
35. Stapel, H., S. C. Kim, S. Osterkamp, P. Knuefermann, A. Hoeft, R. Meyer, C. Grohé, and G. Baumgarten. 2006. Toll-like receptor 4 modulates myocardial ischaemia-reperfusion injury: role of matrix metalloproteinases. Eur. J. Heart Fail. 8: 665-672.
36. Sakata, Y., J. W. Dong, J. G. Vallejo, C. H. Huang, J. S. Baker, K. J. Tracey, O. Tacheuchi, S. Akira, and D. L. Mann. 2007. Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 292: H503-H509.
37. Frisancho-Kiss, S., S. E. Davis, J. F. Nyland, J. A. Frisancho, D. Cihakova, M. A. Barrett, N. R. Rose, and D. Fairweather. 2007. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J. Immunol. 178: 6710-6714. (Pubitemid 46847392)
38. Hua, F., T. Ha, J. Ma, Y. Li, J. Kelley, X. Gao, I. W. Browder, R. L. Kao, D. L. Williams, and C. Li. 2007. Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J. Immunol. 178: 7317-7324. (Pubitemid 46847459)
39. Knuefermann, P., M. Schwederski, M. Velten, P. Krings, H. Ehrentraut, M. Rüdiger, O. Boehm, K. Fink, U. Dreiner, C. Grohé, et al. 2008. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9. Cardiovasc. Res. 78: 26-35.
40. Deschamps, A. M., K. A. Apple, A. H. Leonardi, J. E. McLean, W. M. Yarbrough, R. E. Stroud, L. L. Clark, J. A. Sample, and F. G. Spinale. 2005. Myocardial interstitial matrix metalloproteinase activity is altered by mechanical changes in LV load: interaction with the angiotensin type 1 receptor. Circ. Res. 96: 1110-1118.
41. de Kleijn, D., and G. Pasterkamp. 2003. Toll-like receptors in cardiovascular diseases. Cardiovasc. Res. 60: 58-67.
42. Bradley, J. R. 2008. TNF-mediated inflammatory disease. J. Pathol. 214: 149-160. (Pubitemid 351160153)
43. Monson, N. L. 2008. The natural history of B cells. Curr. Opin. Neurol. 21 (Suppl. 1): S3-S8.
44. Yajima, T., and K. U. Knowlton. 2009. Viral myocarditis: from the perspective of the virus. Circulation 119: 2615-2624.
45. Knowlton, K. U., and B. K. Lim. 2009. Viral myocarditis: is infection of the heart required? J. Am. Coll. Cardiol. 53: 1227-1228.